World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 97 9151 8592 105 96 549 42070

Jorma Paavonen publications per year

The chart shows the history of publications by Jorma Paavonen between 1978 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jorma Paavonen published across 48 years, from 1978 to 2025, averaging 12.1 papers a year. Output peaked at 36 publications in 1989. 7 of the 579 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1978 to 2025. Vertical axis: number of publications, 0 to 36. Peak 36 publications in 1989. 1978: 4 publications 1979: 7 publications 1980: 7 publications 1981: 5 publications 1982: 5 publications 1983: 4 publications 1984: 5 publications 1985: 16 publications 1986: 12 publications 1987: 4 publications 1988: 4 publications 1989: 36 publications 1990: 15 publications 1991: 9 publications 1992: 7 publications 1993: 10 publications 1994: 6 publications 1995: 6 publications 1996: 6 publications 1997: 14 publications 1998: 12 publications 1999: 15 publications 2000: 20 publications 2001: 19 publications 2002: 14 publications 2003: 13 publications 2004: 14 publications 2005: 10 publications 2006: 18 publications 2007: 19 publications 2008: 14 publications 2009: 22 publications 2010: 15 publications 2011: 23 publications 2012: 16 publications 2013: 24 publications 2014: 13 publications 2015: 10 publications 2016: 19 publications 2017: 8 publications 2018: 17 publications 2019: 15 publications 2020: 12 publications 2021: 8 publications 2022: 3 publications 2023: 17 publications 2024: 4 publications 2025: 3 publications
1978 2025

579 publications in total across all disciplines

View publications per year as a table
Jorma Paavonen: publications per year, 1978 to 2025
Year Publications
1978 4
1979 7
1980 7
1981 5
1982 5
1983 4
1984 5
1985 16
1986 12
1987 4
1988 4
1989 36
1990 15
1991 9
1992 7
1993 10
1994 6
1995 6
1996 6
1997 14
1998 12
1999 15
2000 20
2001 19
2002 14
2003 13
2004 14
2005 10
2006 18
2007 19
2008 14
2009 22
2010 15
2011 23
2012 16
2013 24
2014 13
2015 10
2016 19
2017 8
2018 17
2019 15
2020 12
2021 8
2022 3
2023 17
2024 4
2025 3
Total 579
Download as CSV

Jorma Paavonen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jorma Paavonen sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 541–560 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 549 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537 549
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Jorma Paavonen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jorma Paavonen sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 96–97 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 97 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779 97
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Jorma Paavonen is affiliated with the University of Helsinki in Finland and has contributed extensively to research in medicine, particularly within immunology and microbiology. Their work has spanned multiple subfields including epidemiology, microbiology, public health, environmental and occupational health, surgery, and obstetrics and gynecology.

The scientist's research covers various main topics that include:

  • Reproductive tract infections research
  • Cervical cancer and HPV research
  • Hepatitis B virus studies
  • Maternal and perinatal health interventions
  • Genital health and disease
  • Maternal and fetal healthcare
  • Urinary tract infections management

Recent papers authored or co-authored by Jorma Paavonen include:

  • "Association of peripartum management and high maternal blood loss at cesarean delivery for placenta accreta spectrum (PAS): A multinational database study", 2021, published in Acta Obstetricia Et Gynecologica Scandinavica
  • "Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion", 2022, published in Frontiers in Cellular and Infection Microbiology
  • "Vaginitis in Nonpregnant Patients: ACOG Practice Bulletin Number 215", 2020, published in Obstetrics and Gynecology
  • "Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials", 2021, published in The Lancet Infectious Diseases
  • "Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied", 2020, published in The Journal of Infectious Diseases

Frequent co-authors collaborating with Jorma Paavonen include:

  • Matti Lehtinen
  • Vedran Stefanović
  • Minna Tikkanen
  • Tiina Eriksson
  • Robert C. Brunham

The scientist's work is often published in several notable research venues, with multiple publications appearing in:

  • Journal of Perinatal Medicine
  • Frontiers in Cellular and Infection Microbiology
  • The Journal of Infectious Diseases
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Acta Obstetricia Et Gynecologica Scandinavica

Best Publications

  • Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

    Luisa L. Villa;Gonzalo Perez;Susanne K. Kjaer;Jorma Paavonen

  • Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.

    J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler

  • Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

    Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud

  • A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

    LA Koutsky;KK Holmes;CW Critchlow;CE Stevens

  • Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes

    Lawrence Corey;Anna Wald;Raj Patel;Stephen L. Sacks

  • Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Matti Lehtinen;Jorma Paavonen;Cosette M. Wheeler;Unnop Jaisamrarn

  • Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

    Elmar A Joura;Sepp Leodolter;Mauricio Hernandez-Avila;Cosette M Wheeler

  • High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up

    L. L. Villa;R. L. R. Costa;C. A. Petta;R. P. Andrade

  • Chlamydia trachomatis: impact on human reproduction

    J Paavonen;W Eggert-Kruse

  • Pelvic Inflammatory Disease

    Robert C Brunham;Sami L Gottlieb;Jorma Paavonen

  • Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Cosette M. Wheeler;Xavier Castellsagué;Suzanne M. Garland;Anne Szarewski

  • Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.

    Tarja Anttila;Pekka Saikku;Pentti Koskela;Aini Bloigu

  • The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV-Naive Women Aged 16–26 Years

    Darron R. Brown;Susanne K. Kjaer;Kristján Sigurdsson;Ole-Erik Iversen

  • Mucopurulent Cervicitis — The Ignored Counterpart in Women of Urethritis in Men

    Robert C. Brunham;Jorma Paavonen;Claire E. Stevens;Nancy Kiviat

  • Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women

    Nubia Munoz;Susanne K. Kjaer;Kristján Sigurdsson;Ole Erik Iversen

  • Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: Randomized trial 5-year follow-up.

    Ritva Hurskainen;Juha Teperi;Pekka Rissanen;Anna-Mari Aalto

  • Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine

    Sven-Eric Olsson;Luisa L. Villa;Ronaldo L.R. Costa;Carlos A. Petta

  • Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data

    Elmar A. Joura;Suzanne M. Garland;Suzanne M. Garland;Jorma Paavonen;Daron Gale Ferris

  • Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

    Pentti Koskela;Tarja Anttila;Tone Bjørge;Anne Brunsvig

  • Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.

    Ritva Hurskainen;Juha Teperi;Pekka Rissanen;Anna-Mari Aalto

Frequent Co-Authors

Matti Lehtinen
Matti Lehtinen Tampere University
Joakim Dillner
Joakim Dillner Karolinska University Hospital
Suzanne M. Garland
Suzanne M. Garland University of Melbourne
Mika Gissler
Mika Gissler Finnish Institute for Health and Welfare
King K. Holmes
King K. Holmes University of Washington
Eero Pukkala
Eero Pukkala Tampere University
Cosette M. Wheeler
Cosette M. Wheeler University of New Mexico
Nancy B. Kiviat
Nancy B. Kiviat University of Washington
David A. Eschenbach
David A. Eschenbach University of Washington
Gary Dubin
Gary Dubin GlaxoSmithKline (United Kingdom)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, it’s important to explore related online degrees and alternative career routes in healthcare. Many students look for pathways that offer flexibility and specialized focus, allowing them to tailor their education to their career goals.

For those interested in nursing, some programs remove common testing barriers. You may want to consider a nursing school that doesn't require teas, making entry quicker and less stressful.

Administration roles are also in high demand. Completing an online healthcare administration degree can open doors to management positions in hospitals, clinics, and beyond.

Nurses looking for advanced practice roles can enroll in rn to np programs, bridging from an Associate’s Degree in Nursing (ADN) to a Master’s of Science in Nursing (MSN).

Nutrition is another growing field. Earning an online bs in nutrition prepares you for careers in wellness, healthcare, public health, and education.

Exploring these online degrees can help you find the best fit for your ambitions and adapt to the changing needs of the healthcare sector.

Best Scientists Citing Jorma Paavonen

Trending Scientists

Recently Published Articles